Priyanka Nair-Gupta

Title: Celebrating the Innovations of Priyanka Nair-Gupta

Introduction: Priyanka Nair-Gupta is an accomplished inventor based in Spring House, Pennsylvania, known for her work in the field of biotechnology. Her innovative contributions have led to significant advancements in medical treatments, particularly in cancer therapies.

Latest Patents: Priyanka holds a patent titled "Anti-CD33 antibodies, anti-CD33/anti-CD3 bispecific antibodies and uses thereof." This patent describes the development of anti-CD33 antibodies and antigen-binding fragments, as well as anti-CD33/anti-CD3 bispecific antibodies. It includes nucleic acids encoding these antibodies, compositions that comprise them, methods for their production, and applications for treating or preventing diseases such as cancer.

Career Highlights: Priyanka is currently affiliated with Janssen Biotech, Inc., where she continues to apply her expertise in biotechnology. Her research focuses on the design and application of novel antibodies for targeted therapies, contributing to innovative approaches in cancer treatment.

Collaborations: Throughout her career, Priyanka has collaborated with esteemed colleagues such as Michael Diem and Francois Gaudet. These partnerships highlight her dedication to advancing scientific research and fostering innovation in her field.

Conclusion: Priyanka Nair-Gupta is a pioneering inventor whose work in biotherapeutics demonstrates the potential of innovation in medicine. Her patented inventions not only pave the way for new cancer treatments but also embody the spirit of collaboration and research that drives progress in biotechnology.